NCT00099931View on ClinicalTrials.gov

Efficacy and Safety of Vildagliptin in Combination With Insulin in Patients With Type 2 Diabetes

PHASE3CompletedINTERVENTIONAL
Enrollment

254

Participants

Timeline

Start Date

May 31, 2004

Primary Completion Date

June 30, 2005

Study Completion Date

June 30, 2005

Conditions
Diabetes Mellitus, Type 2
Interventions
DRUG

vildagliptin

Trial Locations (1)

Unknown

Novartis Investigative Site, Investigative Sites

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY